Patents by Inventor Fanfeng Ma

Fanfeng Ma has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20180160709
    Abstract: The current invention relates to a gargle dosage formulation and a method for removing the bitter taste in oral medication or food. Particularly, this bitter-removal formulation comprises at least one of two preparations, the first preparation and the second preparation. The current invention also discloses a method of using the preparations before and after taking oral medication or food. Right before taking oral medication or food, the first preparation is used to gargle the user's oral cavity. After it is spat out, the first preparation forms a thin layer on the surface of the oral mucosa to cover, shield, and protect taste buds from the direct contact with oral medication or food. Immediately after oral medication or food is taken, the second preparation is used to gargle and clean the user's taste buds, which effectively elutes mucosa-binding bitter ingredients from the oral cavity.
    Type: Application
    Filed: December 8, 2017
    Publication date: June 14, 2018
    Inventors: Zhongyuan Zhu, Fanfeng Ma, Mu Zhu, Xiyuan Zhu
  • Patent number: 7432245
    Abstract: Parenteral formulations of peptides which are useful for sustained release are disclosed. Also disclosed are methods of preparation for the formulations.
    Type: Grant
    Filed: June 6, 2003
    Date of Patent: October 7, 2008
    Assignee: Abbott Laboratories Inc.
    Inventors: Fortuna Haviv, Bryan K. Erickson, Jack Henkin, Luk C. Li, Fanfeng Ma, Friedrich W. Richter, Yi Shi, Jingfeng Song, Siriporn Toongsuwan
  • Publication number: 20030228365
    Abstract: Parenteral formulations of peptides which are useful for sustained release are disclosed. Also disclosed are methods of preparation for the formulations.
    Type: Application
    Filed: June 7, 2002
    Publication date: December 11, 2003
    Inventors: Fortuna Haviv, Jack Henkin, Luk C. Li, Fanfeng Ma, Yi Shi, Jing Feng Song
  • Publication number: 20030229022
    Abstract: Parenteral formulations of peptides which are useful for sustained release are disclosed. Also disclosed are methods of preparation for the formulations.
    Type: Application
    Filed: June 6, 2003
    Publication date: December 11, 2003
    Inventors: Fortuna Haviv, Bryan K. Erickson, Jack Henkin, Luk C. Li, Fanfeng Ma, Friedrich W. Richter, Yi Shi, Jingfeng Song, Siriporn Toongsuwan
  • Patent number: 6008333
    Abstract: The present invention provides a method for the preparation of disaccharides, such as glucosaminyl muramic acids peptides and derivatives. The method includes condensing a protected muramic acid ester with a 1-organothio- or 1-fluoroglucosamine derivative in the presence of a suitable promoter to produce a protected glucosaminyl muramic acid ester. The protected glucosaminyl muramic acid ester may be used to prepare disaccharide peptides, such as N-acetylglucosaminyl-N-acetylmuramyl dipeptides, which have demonstrated immunological activity. Protected muramic acid esters and 1-organothio- or 1-fluoro-glucosamine compounds which may be employed as intermediates in the method are also provided.
    Type: Grant
    Filed: February 25, 1998
    Date of Patent: December 28, 1999
    Assignee: Endorex Corporation
    Inventors: Gerald J. Vosika, Fanfeng Ma
  • Patent number: 5750665
    Abstract: The present invention provides a method for the preparation of disaccharides, such as glucosaminyl muramic acids peptides and derivatives. The method includes condensing a protected muramic acid ester with a 1-organothio- or 1-fluoroglucosamine derivative in the presence of a suitable promoter to produce a protected glucosaminyl muramic acid ester. The protected glucosaminyl muramic acid ester may be used to prepare disaccharide peptides, such as N-acetylglucosaminyl-N-acetylmuramyl dipeptides, which have demonstrated immunological activity. Protected muramic acid esters and 1-organothio- or 1-fluoro- glucosamine compounds which may be employed as intermediates in the method are also provided.
    Type: Grant
    Filed: October 4, 1995
    Date of Patent: May 12, 1998
    Inventors: Gerald J. Vosika, Fanfeng Ma